Clinical Trial Update: Synergistic Enteral Regimen for Treatment of the Gangliosidoses [Phase 4]

View source ↗

Summary

Phase 4 trial update for a synergistic enteral regimen in GM1 and GM2 gangliosidoses; the study was terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gm1 Gangliosidosis
• Gm2 Gangliosidosis
• Sandhoff Disease
• Tay-sachs Disease

Snippet

Sponsor: University of Minnesota | Conditions: GM1 Gangliosidoses, GM2 Gangliosidoses | Phase 4 | Status: TERMINATED | Results posted: 2021-04-14